Arkin Bio Ventures
Overview
Arkin Bio Ventures is a venture capital firm based in Israel that identifies and invests in innovative early and mid-stage companies with breakthroughs in areas such as immunotherapy, cancer, metabolism, and drug-delivery platforms.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Auron Therapeutics | Feb 2025 | Series B | Co-investor |
| Entact Bio | Dec 2022 | Series A | Co-investor |
| Ambros Therapeutics, Inc. | Dec 2025 | Series A | Co-investor |
| Metabomed | Dec 2019 | Series B | Co-investor |
| Photys Therapeutics | Sep 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Arkin Bio Ventures based?
Arkin Bio Ventures is headquartered in Herzliya, Israel.
When was Arkin Bio Ventures founded?
Arkin Bio Ventures was founded in 2016.
How many portfolio companies does Arkin Bio Ventures have?
Arkin Bio Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in Arkin Bio Ventures's portfolio?
Portfolio companies visible on Caplight include Auron Therapeutics, Entact Bio, Ambros Therapeutics, Inc., Metabomed, Photys Therapeutics.
What was Arkin Bio Ventures's most recent investment shown here?
Arkin Bio Ventures's most recent investment in this portfolio sample was in Ambros Therapeutics, Inc. in 2025.
What sectors does Arkin Bio Ventures focus on?
Arkin Bio Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Arkin Bio Ventures focus on?
Arkin Bio Ventures typically invests at the Early stage.